FTC Warns PBM Practices Are Driving Higher Drug Costs and Employers Start to Push Back

This year, a combination of rising pharmacy costs and increased regulatory risk has led to a tipping point for the PBM industry. In the face of regulatory scrutiny and litigation, US-Rx Care CEO Renzo Luzzatti believes that employers cannot wait for government intervention to change in...